Brief: Beauty Health sees FY2023 sales of USD 450-470 million

Skinhealth Systems

28/02/2023 12:51

Feb 28 (Reuters) - Beauty Health :
* Q4 adjusted gross margin 72.3%
* Q4 adjusted EBITDA margin 16.6%
* Q4 adjusted EBITDA USD 16.3 million
* Q4 net income USD 3.8 million
* Q4 gross profit USD 65.2 million
* Q4 adjusted net income USD 7.4 million
* Outlook FY sales USD 450-470 million